Literature DB >> 32267920

Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer.

Giovanni Bocchialini1, Costanza Lagrasta2, Denise Madeddu2, Giulia Mazzaschi3, Davide Marturano2, Francesco Sogni2, Enrico Maria Silini2, Letizia Gnetti2, Gabriella Becchi2, Michele Rusca1, Paolo Carbognani1, Luigi Ventura1, Cesare Braggio1, Marcello Tiseo3, Federico Quaini4, Luca Ampollini1.   

Abstract

OBJECTIVES: Tumour-infiltrating lymphocytes (TILs) are critically implicated in the clinical outcome and response to immunotherapy in non-small-cell lung cancer (NSCLC) patients. The functional competence of lymphocyte subpopulations is strongly conditioned by their spatial arrangement within the tumour immune microenvironment. The aim of this study was to determine whether the tissue localization of specific TIL subpopulations might have an impact on the risk of recurrence in surgically resected NSCLC.
METHODS: High-speed scanning of whole slide images was performed on immunohistochemically stained tissue sections from 97 NSCLC patients to assess the number and ratio of CD3+, CD8+ and PD-1+ T-lymphocytes. TIL distribution was computed considering the intratumoural (proximal or distal) and peripheral (invasive margin) localization as well as their location within the fibrotic tissue (immune excluded). The tumour proliferative index was assessed by Ki67 labelling. The impact of TILs number and distribution on clinical-pathological characteristics and outcomes were statistically analysed.
RESULTS: High density and percentage of proximal CD8+ TILs and low PD-1-to-CD8 ratio had a positive impact on disease-free-survival (P = 0.03) and overall survival (P = 0.003). An inverse correlation was observed between the abundance of intratumoural CD8+ TILs carrying PD-1 inhibitory receptor and cancer cell proliferation. Cases with high compared to low fraction of immune excluded CD8+ TILs had significantly reduced 5-year overall survival (n events: 22 vs 12; P = 0.04) and disease-free survival (n events: 24 vs 16; P = 0.03) rates while the amount of CD3+ and CD8+ TILs located at the invasive margin had a favourable effect on the clinical course.
CONCLUSIONS: Mapping TIL subpopulations may implement the definition of prognostic parameters in surgically resected NSCLC.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Immune checkpoint; Lung cancer; PD-1/PD-L1; Tumour immune microenvironment; Tumour-infiltrating lymphocytes

Mesh:

Year:  2020        PMID: 32267920     DOI: 10.1093/ejcts/ezaa098

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Tumour immune microenvironment in resected thymic carcinomas as a predictor of clinical outcome.

Authors:  Giovanni Bocchialini; Ana-Iris Schiefer; Leonhard Müllauer; Jürgen Thanner; Jonas Bauer; Felizia Thaler; Maria Laggner; Cecilia Veraar; Walter Klepetko; Konrad Hötzenecker; José Ramon Matilla; Hendrik Jan Ankersmit; Bernhard Moser
Journal:  Br J Cancer       Date:  2022-06-24       Impact factor: 9.075

2.  Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach adenocarcinomas: an integrative pan-cancer analysis.

Authors:  Xingchen Liao; Wei Wang; Baoping Yu; Shiyun Tan
Journal:  Cancer Cell Int       Date:  2022-06-14       Impact factor: 6.429

Review 3.  The state of the art for artificial intelligence in lung digital pathology.

Authors:  Vidya Sankar Viswanathan; Paula Toro; Germán Corredor; Sanjay Mukhopadhyay; Anant Madabhushi
Journal:  J Pathol       Date:  2022-06-20       Impact factor: 9.883

4.  BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.

Authors:  Qiang Ju; Xin-Mei Li; Heng Zhang; Yan-Jie Zhao
Journal:  Front Mol Biosci       Date:  2020-11-02

5.  Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer.

Authors:  Qiang Wang; Danting Zhou; Fang Wu; Qingchun Liang; Qiongzhi He; Muyun Peng; Tianyu Yao; Yan Hu; Banglun Qian; Jingqun Tang; Xiang Wang; Wenliang Liu; Fenglei Yu; Chen Chen
Journal:  Front Oncol       Date:  2021-07-28       Impact factor: 6.244

6.  METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis.

Authors:  Zhipeng Jiang; Wen Yin; Hecheng Zhu; Jun Tan; Youwei Guo; Zhaoqi Xin; Quanwei Zhou; Yudong Cao; Zhaoping Wu; Yirui Kuang; Can Li; Dongcheng Xie; Hailong Huang; Ming Zhao; Xingjun Jiang; Lei Wang; Caiping Ren
Journal:  Cancer Cell Int       Date:  2021-07-19       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.